- Phuong Khanh Morrow has been appointed as Chief Medical Officer at biopharmaceutical company CRISPR Therapeutics (NASDAQ:CRSP).
- Morrow assumes the role on May 23, 2022 and will oversee the firm's global clinical development and regulatory operations.
- She holds over a decade of leadership experience in global drug development, having served as VP and Global Therapeutic Area Head of Hematology, GI Oncology, GU Oncology, and Bone at Amgen (AMGN) most recently.
CRISPR Therapeutics hires Chief Medical Officer
Recommended For You
More Trending News
About CRSP Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CRSP | - | - |
CRISPR Therapeutics AG |